FLUOROURACIL INTAS fluorouracil 250 mg/5 mL injection vial

País: Austrália

Língua: inglês

Origem: Department of Health (Therapeutic Goods Administration)

Ingredientes ativos:

fluorouracil, Quantity: 50 mg/mL

Disponível em:

Accord Healthcare Pty Ltd

Forma farmacêutica:

Injection, solution

Composição:

Excipient Ingredients: sodium hydroxide; water for injections; hydrochloric acid

Via de administração:

Intravenous Infusion, Intravenous

Unidades em pacote:

1 vial

Tipo de prescrição:

(S4) Prescription Only Medicine

Indicações terapêuticas:

Alone or in combination, for the palliative treatment of malignant tumours, particularly of the breast, colon or rectum; and in the treatment of gastric, primary hepatic, pancreatic, uterine (cervical particularly), ovarian and bladder carcinomas.,Fluorouracil should only be used when other proven measures have failed or are considered impractical.

Resumo do produto:

Visual Identification: A clear, colourless to slightly pale yellow solution in a glass vial.; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Status de autorização:

Registered

Data de autorização:

2018-06-08